2021 Investor Alert: Amazon, Google, And Facebook Stockpile Strange Gas
This odorless, colorless gas is critical for every piece of technology you own. However, the world's supply is running dangerously low. This is the time for investors to get in before the mainstream media.
Click HERE To See Why Big Tech Is Hoarding Gas
Andrew Booth, insider at AbCellera Biologics
Andrew Booth Insider Alerts

Get notified the next time Andrew Booth buys or sells AbCellera Biologics stock. Enter your email address below to get our daily insider buying and selling report.

Andrew Booth Insider Information

Andrew became AbCellera’s CFO in 2019 after spending nearly 4 years on the company’s Board of Directors. Prior to joining AbCellera, Andrew spent 10 years at STEMCELL Technologies where he held roles as the CFO and the Chief Commercial Officer. Before STEMCELL, Andrew spent 7 years at General Electric, ending by leading M&A/Business Development for GE Healthcare’s Europe, Middle East, and Africa business and GE Healthcare’s global Life Sciences business based in London. Andrew is Chairman for Precision Nanosystems and a Director at the National Board of Canadian Manufacturers and Exporters. He is also a former Director at the BC Tech Association, at Life Sciences BC and at Light Integra Inc. Andrew holds an MBA from INSEAD and a BASc in Engineering Physics from the University of British Columbia.

How old is Andrew Booth?

Mr. Booth is currently 47 years old. There are 4 older executives and no younger executives at AbCellera Biologics. The oldest executive at AbCellera Biologics is Mr. Tryn T. Stimart Esq., J.D., Chief Legal Officer, Chief Compliance Officer & Corp. Sec., who is 51 years old. Learn More.

How do I contact Andrew Booth?

The corporate mailing address for Mr. Booth and other AbCellera Biologics executives is , , .

Has Andrew Booth been buying or selling shares of AbCellera Biologics?

During the last quarter, Andrew Booth has bought $788,590.00 of AbCellera Biologics stock. Most recently, on Thursday, November 11th, Andrew Booth bought 53,500 shares of AbCellera Biologics stock. The stock was acquired at an average cost of $14.74 per share, with a total value of $788,590.00.

Who are AbCellera Biologics' active insiders?

AbCellera Biologics' insider roster includes Andrew Booth (CFO), John Hamer (Director), Carl Hansen (CEO), Michael Hayden (Director), Veronique Lecault (COO), and John Montalbano (Director).

Are insiders buying or selling shares of AbCellera Biologics?

During the last year, AbCellera Biologics insiders bought shares 3 times. They purchased a total of 262,460 shares worth more than $3,887,659.60. During the last year, insiders at the sold shares 16 times. They sold a total of 41,857,909 shares worth more than $1,016,636,998.35. The most recent insider tranaction occured on November, 11th when CFO Andrew Booth bought 53,500 shares worth more than $788,590.00. Insiders at AbCellera Biologics own 45.8 % of the company.

Information on this page was last updated on 11/11/2021.

Andrew Booth Insider Trading History at AbCellera Biologics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/11/2021Buy53,500$14.74$788,590.00View SEC Filing Icon  
6/9/2021Sell1,200,000$25.50$30,600,000.00View SEC Filing Icon  
See Full Table

Andrew Booth Buying and Selling Activity at AbCellera Biologics

This chart shows Andrew Booth's buying and selling at AbCellera Biologics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AbCellera Biologics Company Overview

AbCellera Biologics logo
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. As of December 31, 2020, the company had 103 discovery programs that are either completed, in progress, or under contract. It has a discovery partnership agreement with Eli Lilly and Company. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada.
Read More

Today's Range

Now: $14.10
Low: $13.73
High: $14.27

50 Day Range

MA: $16.50
Low: $13.96
High: $21.34

2 Week Range

Now: $14.10
Low: $13.18
High: $71.91

Volume

1,362,143 shs

Average Volume

1,884,292 shs

Market Capitalization

$3.97 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
2021 Investor Alert: Amazon, Google, And Facebook Stockpile Strange Gas
This odorless, colorless gas is critical for every piece of technology you own. However, the world's supply is running dangerously low. This is the time for investors to get in before the mainstream media.
Click HERE To See Why Big Tech Is Hoarding Gas